Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | ACOX1 CL E G H | 51 | 119 | OMIM:264470 | Peroxisomal acyl-coa oxidase deficiency | | | | 120 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | ADNP CL E G H | 23394 | 15766 | ORPHA:404448 | ADNP syndrome | HP:0040281 - Very frequent | | | 47 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | ALG11 CL E G H | 440138 | 32456 | ORPHA:280071 | ALG11-CDG | HP:0040281 - Very frequent | | | 41 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | AP2M1 CL E G H | 1173 | 564 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040283 - Occasional | | | | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | CDKL5 CL E G H | 6792 | 11411 | ORPHA:3095 | Atypical Rett syndrome | HP:0040282 - Frequent | | | 405 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | CHD2 CL E G H | 1106 | 1917 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040283 - Occasional | | | 227 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | CHMP1A CL E G H | 5119 | 8740 | OMIM:614961 | Pontocerebellar hypoplasia, type 8 | | | | 19 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | CLTC CL E G H | 1213 | 2092 | OMIM:617854 | Mental retardation, autosomal dominant 56 | | | | 1 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | CNTNAP2 CL E G H | 26047 | 13830 | OMIM:610042 | Pitt-Hopkins-Like syndrome 1 | . | | | 518 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | CREBBP CL E G H | 1387 | 2348 | ORPHA:353281 | Rubinstein-Taybi syndrome due to 16p13.3 microdeletion | HP:0040282 - Frequent | | | 291 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | CREBBP CL E G H | 1387 | 2348 | ORPHA:353277 | Rubinstein-Taybi syndrome due to CREBBP mutations | HP:0040282 - Frequent | | | 291 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | DLK1 CL E G H | 8788 | 2907 | ORPHA:254531 | Temple syndrome due to paternal 14q32.2 hypomethylation | HP:0040283 - Occasional | | | 1 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | DNAJC6 CL E G H | 9829 | 15469 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 6 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | EP300 CL E G H | 2033 | 3373 | ORPHA:353284 | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | HP:0040282 - Frequent | | | 250 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | EXTL3 CL E G H | 2137 | 3518 | ORPHA:508533 | Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome | | | | 3 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | FMR1 CL E G H | 2332 | 3775 | ORPHA:449291 | Symptomatic form of fragile X syndrome in female carriers | HP:0040283 - Occasional | | | 30 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | FOXG1 CL E G H | 2290 | 3811 | OMIM:613454 | Rett syndrome, congenital variant | | | | 177 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | GABBR2 CL E G H | 9568 | 4507 | ORPHA:3095 | Atypical Rett syndrome | HP:0040282 - Frequent | | | 5 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | GFM2 CL E G H | 84340 | 29682 | ORPHA:565624 | Combined oxidative phosphorylation defect type 39 | | | | 43 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | GRIN1 CL E G H | 2902 | 4584 | OMIM:617820 | Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive | | | | 108 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | HERC1 CL E G H | 8925 | 4867 | ORPHA:457359 | Megalencephaly-severe kyphoscoliosis-overgrowth syndrome | HP:0040283 - Occasional | | | 16 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | HTRA2 CL E G H | 27429 | 14348 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 39 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | IQSEC2 CL E G H | 23096 | 29059 | OMIM:309530 | Mental retardation, X-linked 1 | | | | 119 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | IQSEC2 CL E G H | 23096 | 29059 | ORPHA:397933 | Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome | HP:0040282 - Frequent | | | 119 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | LINGO1 CL E G H | 84894 | 21205 | OMIM:618103 | Mental retardation, autosomal recessive 64 | | | | | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | LRRK2 CL E G H | 120892 | 18618 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 221 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | MAN2C1 CL E G H | 4123 | 6827 | OMIM:619775 | CONGENITAL DISORDER OF DEGLYCOSYLATION 2; CDDG2 | | | | | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | MBD5 CL E G H | 55777 | 20444 | OMIM:156200 | Mental retardation, autosomal dominant 1 | | | | 252 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | MECP2 CL E G H | 4204 | 6990 | ORPHA:3095 | Atypical Rett syndrome | HP:0040282 - Frequent | | | 950 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | MECP2 CL E G H | 4204 | 6990 | OMIM:300496 | Autism susceptibility, X-linked 3 | | | | 950 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | MED12 CL E G H | 9968 | 11957 | OMIM:309520 | Lujan-Fryns syndrome | . | | | 228 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | MEG3 CL E G H | 55384 | 14575 | ORPHA:254531 | Temple syndrome due to paternal 14q32.2 hypomethylation | HP:0040283 - Occasional | | | 1 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | NEXMIF CL E G H | 340533 | 29433 | OMIM:300912 | Mental retardation, X-linked 98 | | | | 52 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | NEXMIF CL E G H | 340533 | 29433 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040283 - Occasional | | | 52 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | NF1 CL E G H | 4763 | 7765 | ORPHA:97685 | 17q11 microdeletion syndrome | HP:0040281 - Very frequent | | | 1952 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | NLGN1 CL E G H | 22871 | 14291 | OMIM:618830 | Autism, susceptibility to, 20 | . | | | 4 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | NLGN3 CL E G H | 54413 | 14289 | OMIM:300494 | Asperger syndrome, X-linked, susceptibility to, 1 | | | | 24 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | NLGN3 CL E G H | 54413 | 14289 | OMIM:300425 | Autism susceptibility, X-linked 1 | | | | 24 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | NLGN4X CL E G H | 57502 | 14287 | OMIM:300497 | Asperger syndrome susceptibility, X-linked 2 | | | | 57 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | NLGN4X CL E G H | 57502 | 14287 | OMIM:300495 | Autism, susceptibility to, X-linked 2 | | | | 57 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | NTNG1 CL E G H | 22854 | 23319 | ORPHA:3095 | Atypical Rett syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | OPHN1 CL E G H | 4983 | 8148 | ORPHA:137831 | X-linked intellectual disability-cerebellar hypoplasia syndrome | HP:0040282 - Frequent | | | 55 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | PARK7 CL E G H | 11315 | 16369 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 23 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | PINK1 CL E G H | 65018 | 14581 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 55 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | PLA2G6 CL E G H | 8398 | 9039 | OMIM:256600 | Neurodegeneration with brain iron accumulation 2A | | | | 133 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | PODXL CL E G H | 5420 | 9171 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 6 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | POLA1 CL E G H | 5422 | 9173 | ORPHA:163976 | X-linked intellectual disability, Van Esch type | HP:0040281 - Very frequent | | | 2 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | PRKN CL E G H | 5071 | 8607 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 138 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | PUS3 CL E G H | 83480 | 25461 | OMIM:617051 | MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55; MRT55 | | | | 1 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | RTL1 CL E G H | 388015 | 14665 | ORPHA:254531 | Temple syndrome due to paternal 14q32.2 hypomethylation | HP:0040283 - Occasional | | | | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SCN1A CL E G H | 6323 | 10585 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040283 - Occasional | | | 1053 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SH2B1 CL E G H | 25970 | 30417 | ORPHA:261197 | Proximal 16p11.2 microdeletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SH2B1 CL E G H | 25970 | 30417 | ORPHA:329249 | Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency | HP:0040281 - Very frequent | | | | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SHANK3 CL E G H | 85358 | 14294 | OMIM:606232 | Phelan-Mcdermid syndrome | | | | 53 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040283 - Occasional | | | 255 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SLC6A1 CL E G H | 6529 | 11042 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040283 - Occasional | | | 29 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SLC6A8 CL E G H | 6535 | 11055 | OMIM:300352 | Creatine deficiency syndrome, X-linked | . | | | 122 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SMC1A CL E G H | 8243 | 11111 | ORPHA:3095 | Atypical Rett syndrome | HP:0040282 - Frequent | | | 135 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SNCA CL E G H | 6622 | 11138 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 65 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SNRPN CL E G H | 6638 | 11164 | OMIM:209850 | Autism susceptibility 1 | | | | 37 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SNRPN CL E G H | 6638 | 11164 | ORPHA:177907 | Prader-Willi syndrome due to translocation | HP:0040283 - Occasional | | | 37 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SPTBN1 CL E G H | 6711 | 11275 | OMIM:619475 | DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA | | | | | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SYNGAP1 CL E G H | 8831 | 11497 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040283 - Occasional | | | 108 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SYNGAP1 CL E G H | 8831 | 11497 | ORPHA:544254 | SYNGAP1-related developmental and epileptic encephalopathy | HP:0040283 - Occasional | | | 108 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | SYNJ1 CL E G H | 8867 | 11503 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 9 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | TBR1 CL E G H | 10716 | 11590 | OMIM:606053 | Intellectual developmental disorder with autism and speech delay | . | | | 1 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | TET3 CL E G H | 200424 | 28313 | OMIM:618798 | BECK-FAHRNER SYNDROME; BEFAHRS | | | | | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | TRIM8 CL E G H | 81603 | 15579 | OMIM:619428 | FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND NEURODEVELOPMENTAL SYNDROME; FSGSNEDS | | | | 1 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | TUBB3 CL E G H | 10381 | 20772 | ORPHA:300570 | Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation | HP:0040283 - Occasional | | | 64 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | UCHL1 CL E G H | 7345 | 12513 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 21 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | VPS13C CL E G H | 54832 | 23594 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 8 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | WARS2 CL E G H | 10352 | 12730 | OMIM:619738 | PARKINSONISM-DYSTONIA 3, CHILDHOOD-ONSET; PKDYS3 | | | | 2 | | |
HP:0000735 | HP:0000735 | Impaired social interactions | 0 | ZMYND11 CL E G H | 10771 | 16966 | OMIM:616083 | Mental retardation, autosomal dominant 30 | | | | 24 | | |
HP:0000735 | HP:4000085 | Reduced object sharing | 1 | CL E G H | | | | | | | | | | |
HP:0000735 | HP:4000084 | Reduced sharing of interests | 1 | CL E G H | | | | | | | | | | |
HP:0000735 | HP:4000083 | Absence of interest in peers | 1 | CL E G H | | | | | | | | | | |
HP:0000735 | HP:4000082 | Reduced collaborative play | 1 | CL E G H | | | | | | | | | | |
HP:0000735 | HP:4000080 | Lack of social initiations | 1 | CL E G H | | | | | | | | | | |
HP:0000735 | HP:0008763 | No social interaction | 1 | ACOX1 CL E G H | 51 | 119 | OMIM:264470 | Peroxisomal acyl-coa oxidase deficiency | . | | | 120 | | |
HP:0000735 | HP:0002332 | Lack of peer relationships | 1 | AP2M1 CL E G H | 1173 | 564 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040282 - Frequent | | | | | |
HP:0000735 | HP:0002332 | Lack of peer relationships | 1 | CHD2 CL E G H | 1106 | 1917 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040282 - Frequent | | | 227 | | |
HP:0000735 | HP:0008763 | No social interaction | 1 | EXTL3 CL E G H | 2137 | 3518 | ORPHA:508533 | Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome | HP:0040283 - Occasional | | | 3 | | |
HP:0000735 | HP:0008763 | No social interaction | 1 | GFM2 CL E G H | 84340 | 29682 | ORPHA:565624 | Combined oxidative phosphorylation defect type 39 | HP:0040282 - Frequent | | | 43 | | |
HP:0000735 | HP:0008763 | No social interaction | 1 | IQSEC2 CL E G H | 23096 | 29059 | OMIM:309530 | Mental retardation, X-linked 1 | | | | 119 | | |
HP:0000735 | HP:0002332 | Lack of peer relationships | 1 | MECP2 CL E G H | 4204 | 6990 | OMIM:300496 | Autism susceptibility, X-linked 3 | . | | | 950 | | |
HP:0000735 | HP:0002332 | Lack of peer relationships | 1 | NEXMIF CL E G H | 340533 | 29433 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040282 - Frequent | | | 52 | | |
HP:0000735 | HP:0000728 | Impaired ability to form peer relationships | 1 | NLGN3 CL E G H | 54413 | 14289 | OMIM:300494 | Asperger syndrome, X-linked, susceptibility to, 1 | . | | | 24 | | |
HP:0000735 | HP:0002332 | Lack of peer relationships | 1 | NLGN3 CL E G H | 54413 | 14289 | OMIM:300425 | Autism susceptibility, X-linked 1 | . | | | 24 | | |
HP:0000735 | HP:0000728 | Impaired ability to form peer relationships | 1 | NLGN4X CL E G H | 57502 | 14287 | OMIM:300497 | Asperger syndrome susceptibility, X-linked 2 | . | | | 57 | | |
HP:0000735 | HP:0002332 | Lack of peer relationships | 1 | NLGN4X CL E G H | 57502 | 14287 | OMIM:300495 | Autism, susceptibility to, X-linked 2 | . | | | 57 | | |
HP:0000735 | HP:0002332 | Lack of peer relationships | 1 | SCN1A CL E G H | 6323 | 10585 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040282 - Frequent | | | 1053 | | |
HP:0000735 | HP:0008763 | No social interaction | 1 | SH2B1 CL E G H | 25970 | 30417 | ORPHA:329249 | Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency | HP:0040282 - Frequent | | | | | |
HP:0000735 | HP:0002332 | Lack of peer relationships | 1 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040282 - Frequent | | | 255 | | |
HP:0000735 | HP:0002332 | Lack of peer relationships | 1 | SLC6A1 CL E G H | 6529 | 11042 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040282 - Frequent | | | 29 | | |
HP:0000735 | HP:0000728 | Impaired ability to form peer relationships | 1 | SNRPN CL E G H | 6638 | 11164 | OMIM:209850 | Autism susceptibility 1 | . | | | 37 | | |
HP:0000735 | HP:0002332 | Lack of peer relationships | 1 | SYNGAP1 CL E G H | 8831 | 11497 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040282 - Frequent | | | 108 | | |
HP:0000735 | HP:0008763 | No social interaction | 1 | TRIM8 CL E G H | 81603 | 15579 | OMIM:619428 | FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND NEURODEVELOPMENTAL SYNDROME; FSGSNEDS | | | | 1 | | |